TC2N predicts favorable prognosis and shows potential as therapeutic target for breast cancer
Jan. 8, 2024
Researchers from Third Military Medical University of the Chinese PLA have published data from a study that aimed to investigate the biological functions and molecular mechanisms of tandem C2 domains, nuclear (TC2N) in the development and progression of breast cancer.